Cite
HARVARD Citation
Nishio, S. et al. (n.d.). 2022-RA-680-ESGO Safety and efficacy of MORAb-202 in patients with platinum-resistant ovarian cancer: results from the expansion part of a phase 1 trial in Japan. International journal of gynecological cancer. pp. A253-A254. [Online].